Effectiveness of Tofacitinib in Pre-adolescent Alopecia Areata: A Retrospective Case Series and Literature Review
Alopecia areata (AA) is a common cause of hair loss in children. Despite numerous therapeutic options for paediatric AA, none have been found to be both effective and safe. Recent studies have demonstrated the efficacy and safety of the Janus kinase (JAK) inhibitor tofacitinib in adult patients with...
Saved in:
Main Authors: | Jundong Huang (Author), Tingting Li (Author), Zixin Tan (Author), Yan Tang (Author), Ji Li (Author), Fenfang Liu (Author), Wei Shi (Author) |
---|---|
Format: | Book |
Published: |
Medical Journals Sweden,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug Survival and Long-term Outcome of Tofacitinib in Patients with Alopecia Areata: A Retrospective Study
by: Jundong Huang, et al.
Published: (2023) -
Effectiveness and Predictive Factors of Response to Tofacitinib Therapy in 125 Patients with Alopecia Areata: A Single-centre Real-world Retrospective Study
by: Jundong Huang, et al.
Published: (2023) -
Dupliumab therapy for alopecia areata: a case series and review of the literature
by: Jundong Huang, et al.
Published: (2024) -
Transient Efficacy of Tofacitinib in Alopecia Areata Universalis
by: Florian Anzengruber, et al.
Published: (2016) -
Pattern hair loss distribution: a novel presentation for alopecia areata
by: Jundong Huang, et al.
Published: (2023)